Lunai Bioworks Inc.
LNAINasdaqCIK 1527728HealthcareFiscal year ends Jun 30
Reports and events: 305 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2321:38 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001362 |
| 2026-10-1521:13 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-26-012970 |
| 2026-10-1316:55 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001731122-26-001339 |
| 2026-10-0914:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-001333 |
| 2026-06-1716:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000871 |
| 2026-06-1616:00 ET | 8-K | 8.01 Other events | 0001731122-26-000865 |
| 2026-05-2009:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000759 |
| 2026-05-1516:46 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001731122-26-000749 |
| 2026-05-1316:45 ET | 8-K | 5.07 Shareholder vote results | 0001731122-26-000718 |
| 2026-05-1117:30 ET | 8-K/A | 3.01 Delisting notice | 0001731122-26-000705 |
| 2026-05-0117:17 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-26-000653 |
| 2026-04-2817:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000623 |
| 2026-04-1317:15 ET | DEF 14A | Proxy statementPeriod 2026-04-13 | 0001731122-26-000559 |
| 2026-03-3017:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001731122-26-000502 |
| 2026-03-0516:46 ET | 8-K | 8.01 Other events | 0001731122-26-000345 |
| 2026-02-2316:33 ET | 8-K | 3.01 Delisting notice | 0001731122-26-000282 |
| 2026-02-1715:16 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001731122-26-000253 |
| 2026-02-1216:15 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure | 0001731122-26-000221 |
| 2025-12-0917:43 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-017804 |
| 2025-12-0321:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-25-001625 |
| 2025-11-2817:51 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-017353 |
| 2025-11-2516:45 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001731122-25-001597 |
| 2025-11-1416:08 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001731122-25-001544 |
| 2025-11-1217:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-016346 |
| 2025-11-0616:22 ET | 8-K | 3.01 Delisting notice | 0001731122-25-001495 |
| 2025-11-0316:31 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001731122-25-001465 |
| 2025-10-3009:15 ET | 8-K | 3.01 Delisting notice | 0001731122-25-001446 |
| 2025-10-1615:21 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001731122-25-001399 |
| 2025-10-1512:06 ET | DEF 14A | Proxy statementPeriod 2025-10-15 | 0001731122-25-001378 |
| 2025-09-2915:56 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001731122-25-001316 |
| 2025-09-2416:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001297 |
| 2025-09-0517:12 ET | 8-K | 2.06 Material impairments; 8.01 Other events | 0001731122-25-001204 |
| 2025-08-2616:45 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001731122-25-001173 |
| 2025-08-0611:51 ET | 8-K | 3.01 Delisting notice | 0001731122-25-001076 |
| 2025-07-3013:08 ET | DEF 14A | Proxy statementPeriod 2025-07-30 | 0001731122-25-001053 |
| 2025-07-2517:13 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001731122-25-001030 |
| 2025-07-1409:18 ET | 8-K | 3.01 Delisting notice | 0001731122-25-000971 |
| 2025-07-1018:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-010280 |
| 2025-07-0919:43 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000948 |
| 2025-06-0516:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001731122-25-000829 |
| 2025-05-1516:31 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001731122-25-000765 |
| 2025-04-1817:00 ET | 8-K | 3.01 Delisting notice | 0001731122-25-000592 |
| 2025-04-1421:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001214659-25-005865 |
| 2025-04-1016:55 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001731122-25-000562 |
| 2025-03-0616:20 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001731122-25-000354 |
| 2025-02-2816:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001731122-25-000312 |
| 2025-02-1916:02 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001731122-25-000258 |
| 2025-02-1909:00 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-09-30 | 0001731122-25-000254 |
| 2025-02-1908:55 ET | 10-K/A | Annual report, amendedPeriod 2024-06-30 | 0001731122-25-000252 |
| 2025-02-1908:50 ET | 10-Q/A | Quarterly report, amendedPeriod 2024-03-31 | 0001731122-25-000250 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 06:04 ET. Listed shows no prices and gives no investment advice.